Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomised, double-blind, placebo-controlled, single- and multiple-, ascending-dose study of the safety, tolerability, and pharmacokinetics and pharmacodynamics of VRG50635 and food effect in healthy volunteers (phase Ia) and multiple-dose study in subjects with amyotrophic lateral sclerosis

Next Previous
Search
Trial Profile

A randomised, double-blind, placebo-controlled, single- and multiple-, ascending-dose study of the safety, tolerability, and pharmacokinetics and pharmacodynamics of VRG50635 and food effect in healthy volunteers (phase Ia) and multiple-dose study in subjects with amyotrophic lateral sclerosis

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 09 Oct 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs VRG-50635 (Primary)
  • Indications Amyotrophic lateral sclerosis
  • Focus Adverse reactions; First in man
  • Sponsors Verge Genomics

    • Most Recent Events

    • 04 Oct 2023 Status changed from active, no longer recruiting to completed.
    • 22 Sep 2023 Status changed from recruiting to active, no longer recruiting.
    • 15 Jun 2023 According to a Verge Genomics media release, detailed results from the study will be presented at the upcoming European Network to Cure ALS (ENCALS) 2023 meeting being held in Barcelona, Spain from July 12-14, 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top